Results 1 to 10 of about 401,548 (249)
Risk factors for thrombocytopenia associated with intravenous valproic acid therapy in pediatric patients undergoing neurosurgical operations [PDF]
Scientific ReportsThrombocytopenia is one of the side effects of VPA. This study aimed to evaluate the incidence and risk factors of thrombocytopenia after intravenous VPA treatment in children with neurosurgical operations.
Zhaosong Du +4 more
doaj +2 more sources
Clinicopathological Characteristics and Outcomes of Lupus Nephritis Patients With Thrombocytopenia: A Single‐Center Retrospective Study [PDF]
Immunity, Inflammation and DiseaseObjectives The objective of this study is to analyze and summarize the clinical characteristics and prognosis of lupus nephritis (LN) patients with thrombocytopenia and to improve the cognition of the disease.
Hui Diao +7 more
doaj +2 more sources
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
New England Journal of Medicine, 2021 Background Several cases of unusual thrombotic events and thrombocytopenia have developed after vaccination with the recombinant adenoviral vector encoding the spike protein antigen of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (ChAdOx1
A. Greinacher +5 more
semanticscholar +2 more sources
Thrombocytopenia in hypertensive disorder of pregnancy: maternal and perinatal outcome [PDF]
New Indian Journal of OBGYN, 2022 Background: Pregnancy induced hypertension (PIH) is one of the most common causes of both maternal and neonatal morbidity. A variety of haematological abnormalities may occur in women with PIH of which thrombocytopenia is the most common.
Varsha Deshmukh +2 more
doaj +1 more source
Understanding Immune Thrombocytopenia: Looking Out of the Box
Frontiers in Medicine, 2021 The pathogenesis of immune thrombocytopenia (ITP) is increasingly being elucidated, and its etiology is becoming more frequently identified, leading to a diagnostic shift from primary to secondary ITP.
Alexandra Schifferli +8 more
doaj +1 more source
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
New England Journal of Medicine, 2021 Summary We report findings in five patients who presented with venous thrombosis and thrombocytopenia 7 to 10 days after receiving the first dose of the ChAdOx1 nCoV-19 adenoviral vector vaccine against coronavirus disease 2019 (Covid-19).
N. H. Schultz +10 more
semanticscholar +1 more source
Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis
New England Journal of Medicine, 2021 Background Vaccine-induced immune thrombocytopenia and thrombosis (VITT) is a new syndrome associated with the ChAdOx1 nCoV-19 adenoviral vector vaccine against severe acute respiratory syndrome coronavirus 2. Data are lacking on the clinical features of
S. Pavord +8 more
semanticscholar +1 more source
Thrombocytopenia is more Frequent in Gram negative Neonatal Septicemia [PDF]
Pediatric Sciences Journal, 2022 Background: Sepsis is one of the major causes of neonatal thrombocytopenia. Aim of the work: To identify the frequency, severity, and clinical outcome of thrombocytopenia associated with culture-proven neonatal septicemia in the Neonatal Intensive ...
Eman Abobakr Abd Alazem +3 more
doaj +1 more source
SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia
New England Journal of Medicine, 2021 The coronavirus disease 2019 (Covid-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) stimulated the development of highly effective vaccines that were produced wi...
D. Cines, J. Bussel
semanticscholar +1 more source
Journal of the American Medical Association (JAMA), 2021 Importance Cerebral venous sinus thrombosis (CVST) with thrombocytopenia, a rare and serious condition, has been described in Europe following receipt of the ChAdOx1 nCoV-19 vaccine (Oxford/AstraZeneca), which uses a chimpanzee adenoviral vector.
I. See +23 more
semanticscholar +1 more source